Sylwer fod y cymhwysiad hwn dan ddatblygiad. Os ydych chi'n gweld unrhyw gamgymeriadau neu os nad yw rhywbeth yn gweithio, cysylltwch â ni yn evidence.service@wales.nhs.uk.

Tobacco: preventing uptake, promoting quitting and treating dependence: update [K] Evidence review for cessation and harm-reduction treatments

National Institute for Health and Care Excellence (2021)

NICE - ISBN: 978-1-4731-4347-0

Mapiau Tystiolaeth

  • Lleoliadau Gofal: Lleoliad gofal iechyd
  • Lleoliadau Gofal: Lleoliad gweithle
  • Grwpiau Poblogaeth: Oedolion
  • Ymyriadau: Bupropian
  • Ymyriadau: Aml-gydran
  • Ymyriadau: Systemau Dosbarthu Nicotin Electronig
  • Ymyriadau: Therapi Amnewid Nicotin
  • Ymyriadau: Varenicline
  • Canlyniad: Rhoi'r gorau i ysmygu
  • Canlyniad: Newidiadau i gyfraddau ysmygu
  • Canlyniad: Atal ailwaelu ysmygu

Math o Dystiolaeth

Adolygiad Sylfaenol NICE

Trosolwg

Mae'r awduron yn datgan:

"Electronic cigarettes (e-cigarettes) are a relatively new technology. Commonly used pharmacotherapies for cessation include NRT, varenicline and bupropion. The relative effectiveness of these treatments compared with e-cigarettes is unclear and may affect patient choice. The main aim of this review is to establish which interventions are the most effective and cost effective for cessation at 6 months. The review will also separately consider the effectiveness of e-cigarettes for shorter term cessation (1-<6 months; question 1a.i.) to compare with the longer term results."

Argymhellion

Mae'r awduron yn datgan:

This evidence review supports recommendations 1.12.1 to 1.12.6, 1.12.13 to 1.12.17, 1.14.19, 1.22.1 to 1.22.2, 1.22.14, and the research recommendations on health effects of e-cigarettes, stop-smoking interventions for under-served groups, support for people with mental health conditions to stop smoking, e-cigarettes for harm reduction, use of e-cigarettes (amount and frequency), and e-cigarette flavours. Other evidence supporting these recommendations can be found in the evidence reviews on barriers and facilitators to e-cigarettes (review L), long-term health effects of e-cigarettes (review M), smoking relapse prevention (review N) and tailored interventions for those with mental health conditions (review O).